BPC-157 Compounded

BPC-157 is a compounded peptide based on a sequence found in gastric juice. Active adults most often ask about it during recovery blocks and for gut-lining support.

Preclinical research focuses on BPC-157's role in normal tissue-repair signaling and blood-vessel formation. Human data is limited, which is why clinician oversight matters here.

• Adults working through a recovery phase after heavy training or physical work
• People discussing gut-lining support with their clinician

Subcutaneous injection, typically daily across a defined cycle. Your prescriber sets dose, site, and duration.

Recovery timelines are individual. Protocols are usually run for the full cycle and then reviewed.

• Human clinical evidence is limited; your clinician will discuss the current state of the evidence with you.
• Disclose any history of cancer - this is a screening consideration for repair-focused peptides.
• Injection-site reactions are the most common report.
• Share your full medication list, medical history, and any allergies during intake.
• Not for use if you are pregnant, planning pregnancy, or breastfeeding unless your clinician says otherwise.
• Stop use and contact your clinician or seek medical care if you experience an unexpected or severe reaction.

Is this FDA-approved?

This is a compounded medication prepared by a licensed US pharmacy for an individual patient. Compounded preparations are not FDA-approved products and are only dispensed after a licensed clinician reviews your intake and determines the therapy is appropriate for you.

Is it a substitute for physical therapy?

No. It is used alongside - never instead of - appropriate medical care and rehab.